X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (70) 70
humans (69) 69
transplantation (69) 69
index medicus (61) 61
adult (54) 54
male (54) 54
female (52) 52
middle aged (52) 52
immunology (40) 40
aged (39) 39
hematology, oncology and palliative medicine (39) 39
hematopoietic stem cells (33) 33
disease-free survival (28) 28
stem cells (27) 27
bone marrow (25) 25
article (24) 24
bone-marrow-transplantation (24) 24
recurrence (24) 24
treatment outcome (24) 24
hematopoietic stem cell transplantation - methods (23) 23
adolescent (21) 21
chemotherapy (20) 20
retrospective studies (20) 20
transplantation, homologous (20) 20
cancer (19) 19
oncology (19) 19
versus-host-disease (19) 19
hematopoietic stem cell transplantation (18) 18
analysis (17) 17
survival (17) 17
young adult (17) 17
hematologic malignancies (16) 16
stem-cell transplantation (16) 16
transplantation, autologous (16) 16
leukemia (15) 15
transplantation conditioning - methods (15) 15
acute myeloid-leukemia (14) 14
mortality (14) 14
survival analysis (14) 14
cyclophosphamide (13) 13
survival rate (13) 13
blood (11) 11
hematopoietic stem cell transplantation - mortality (11) 11
multiple myeloma (11) 11
therapy (11) 11
tissue donors (11) 11
care and treatment (10) 10
graft vs host disease - prevention & control (10) 10
hematologic neoplasms - therapy (10) 10
hematopoietic stem cell transplantation - adverse effects (10) 10
kaplan-meier estimate (10) 10
research (10) 10
haploidentical (9) 9
lymphomas (9) 9
outcomes (9) 9
relapse (9) 9
remission induction (9) 9
surgical procedures, operative (9) 9
aml (8) 8
cyclophosphamide - therapeutic use (8) 8
graft vs host disease - etiology (8) 8
high-risk (8) 8
immunotherapy (8) 8
t cells (8) 8
time factors (8) 8
transplantation conditioning (8) 8
unrelated donors (8) 8
allogeneic (7) 7
allogeneic transplantation (7) 7
follow-up studies (7) 7
graft vs host disease - mortality (7) 7
hematologic neoplasms - mortality (7) 7
hemopoiesis (7) 7
leukemia, myeloid, acute - therapy (7) 7
medical colleges (7) 7
multiple myeloma - therapy (7) 7
risk factors (7) 7
stem cell transplantation (7) 7
usage (7) 7
abridged index medicus (6) 6
child (6) 6
cyclophosphamide - administration & dosage (6) 6
grafts (6) 6
histocompatibility testing (6) 6
immunosuppressive agents - therapeutic use (6) 6
leukemia, myeloid, acute - mortality (6) 6
medical research (6) 6
medicine, experimental (6) 6
non-hodgkins-lymphoma (6) 6
oncology, experimental (6) 6
patient outcomes (6) 6
peripheral-blood (6) 6
precursor cell lymphoblastic leukemia-lymphoma - therapy (6) 6
proportional hazards models (6) 6
rituximab (6) 6
siblings (6) 6
acute disease (5) 5
acute myelogenous leukemia (5) 5
adults (5) 5
antineoplastic agents - therapeutic use (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 2nd ed., ISBN 0763757071, vi, 144
Book
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1770 - 1781
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 2, pp. 143 - 153
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 06/2018, Volume 53, Issue 6, pp. 756 - 763
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3333 - 3333
HLA-haploidentical (haplo) stem cell transplantation is now widely used for patients lacking a suitably matched related or unrelated donor (MUD).... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4541 - 4541
Unmanipulated T-cell replete HLA-mismatched haploidentical transplantation (haplo) with post-transplant cyclophosphamide (PTCY) is now widely used for patients... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4479 - 4479
Phase II trial evaluating the Efficacy and Safety of Sargramostim Post Infusion of T -Replete HLA Mismatched Peripheral Blood Haploidentical Hematopoietic Stem... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2014 - 2014
Relapse of leukemia (RL) is the most common cause of treatment failure following allogeneic hematopoietic cell transplantation (alloHCT) in patients with AML.... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2006 - 2006
Severe (grade 3-4) acute GVHD (aGVHD) and NIH grade severe chronic GVHD (cGVHD) have historically been associated with poor survival. However, earlier... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 82 - 82
Abstract The fludarabine, high dose cytarabine and G_CSF with or without idarubicin combination regimen, referred to as FLAG+/-Ida, is commonly used as a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3368 - 3368
Abstract Haploidentical donor (HID) transplant with post-transplant cyclophosphamide (PTCy) is being increasingly utilized worldwide. Although the original... 
Journal Article
Blood Reviews, ISSN 0268-960X, 2016, Volume 30, Issue 5, pp. 333 - 339
Abstract Extramedullary leukemia (EM AML), also known as myeloid sarcoma, is a rare manifestation of acute myelogenous leukemia and often accompanies bone... 
Hematology, Oncology and Palliative Medicine | Myelogenous | Therapy | Leukemia | Extramedullary | Leukemia, Myeloid, Acute | Humans | Chemotherapy | Sarcoma | Stem cells | Bone marrow | Cytogenetics | Transplantation | Lymphomas | Cancer
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2018, Volume 54, Issue 8, pp. 1218 - 1226
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 05/2018, Volume 53, Issue 5, pp. 521 - 534
Journal Article